rfhg_1615.1

Basic information about the TSS

---

TSS ID: rfhg_1615.1 Species: human Chr: chr1		Start: 11736070 End: 11736080 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2127212,EH38E1319055)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000376637.7:4 GeneID: 57085 HGNC/MGI_ID: HGNC:13539 UniProt_ID: Q6RW13 Nearer transcript ids and distances: ENST00000476512.5:37 ENST00000400895.6:44 ENST00000494437.1:50 ENST00000314340.10:56 NM_001040195.2:56 NM_001040194.2:56 NM_020350.5:56 NM_001040196.2:56 NM_001040197.2:56 ENST00000491346.5:62 AK290042:62 ENST00000376629.8:67 BC017328:67 ENST00000376627.6:73 AF312374:75 ENST00000452018.6:93 ENST00000510878.1:95 BC011946:99 KJ899301:122 AB528670:129 DQ892619:129 DQ895859:129 AF165187:129 view more...

Gene_name: angiotensin II receptor associated protein Gene_symbol: AGTRAP Gene_synonyms: ATRAP Gene_source: HGNC:13539

TATA-Box annotation

---

Distance to TSS:	-10
Nearest PromoterID:	NM_001040196
Entrez ID:	57085
Nearest Unigene:	Hs.464438
Nearest Refseq:	NM_020350
Nearest Ensembl:	ENSG00000177674
Gene Name:	angiotensin II receptor associated protein
Gene Alias:	ATRAP
Gene Type:	protein-coding
CpG%:	0.100000
GC%:	0.545455
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@AGTRAP p2@AGTRAP p3@AGTRAP
Sample		p1@AGTRAP	p2@AGTRAP	p3@AGTRAP
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	12.86	3.31	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	11.94	2.43	3.44
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	11.19	3.67	2.89
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	9.98	2.08	2.49
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	11.92	2.25	2.25
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	9.50	3.49	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	14.38	3.27	3.05
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	7.27	4.60	5.33
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.90	4.70	4.92
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	7.54	3.48	5.80
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	8.49	2.83	4.85
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	10.98	2.03	6.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	56.58	2.26	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	50.22	0.60	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	52.03	0.88	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	50.55	0.50	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	40.62	0.22	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	40.49	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	43.19	0.53	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	53.41	1.35	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	50.52	1.47	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	53.51	1.55	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	46.92	0.90	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	46.59	0.49	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	50.57	0.26	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	58.87	2.85	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	46.15	2.20	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	51.16	1.89	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	47.65	2.26	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	49.40	2.35	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	56.52	0.84	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	53.93	1.76	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	46.00	1.48	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	36.62	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	56.10	2.62	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	57.49	1.15	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	63.77	2.25	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	61.05	1.01	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	66.18	2.43	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	64.10	2.40	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	57.40	1.88	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	39.09	1.17	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	68.75	1.27	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	69.41	2.45	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	66.66	2.41	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	75.38	2.56	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	82.29	2.88	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	78.69	1.79	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	85.22	3.35	1.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	77.64	2.02	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	82.39	1.84	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	101.18	4.00	2.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	84.46	2.13	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	84.83	3.98	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	19.30	1.68	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	42.25	1.38	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	86.21	3.57	2.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	93.14	3.53	3.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	38.66	5.34	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	100.82	2.82	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	93.65	1.68	5.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	12.74	2.39	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	40.43	4.08	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	87.08	2.60	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	93.36	4.26	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	0.00	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	73.13	4.39	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	89.26	2.98	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	49.73	5.16	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	38.75	4.31	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	64.34	1.55	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	65.43	2.75	0.92
Adipocyte - breast, donor1	11376-118A8	61.77	2.38	1.90
Adipocyte - breast, donor2	11327-117E4	33.53	2.09	1.44
Adipocyte - omental, donor1	11473-119C6	59.16	2.04	1.27
Adipocyte - omental, donor2	11474-119C7	56.06	6.73	2.24
Adipocyte - omental, donor3	11475-119C8	46.22	3.68	2.01
Adipocyte - perirenal, donor1	11476-119C9	61.25	3.19	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	18.69	1.10	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	22.58	2.71	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	10.43	0.87	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	68.65	2.15	1.76
Adipocyte differentiation, day04, donor2	13022-139D7	58.17	1.29	2.06
Adipocyte differentiation, day04, donor3	13025-139E1	69.41	3.62	1.95
Adipocyte differentiation, day04, donor4	13028-139E4	69.36	3.53	3.53
Adipocyte differentiation, day08, donor1	13020-139D5	15.60	0.80	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	42.28	1.29	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	19.19	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	32.83	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	30.78	0.83	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	46.21	1.76	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	23.89	1.31	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	23.14	0.91	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	57.68	5.52	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	81.40	12.55	4.66
Alveolar Epithelial Cells, donor3	11671-122G6	76.67	5.99	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	11.69	0.90	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	15.06	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	27.32	1.23	1.03
Anulus Pulposus Cell, donor1	11248-116E6	23.11	0.92	0.57
Anulus Pulposus Cell, donor2	11463-119B5	25.96	1.96	1.96
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	52.57	2.25	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	49.93	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	59.93	2.14	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	47.53	2.69	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	48.06	6.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	52.81	3.30	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	48.41	3.90	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	40.29	3.88	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	46.32	1.78	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	45.20	1.88	3.01
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	53.70	1.45	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	58.93	2.51	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	53.05	3.46	1.65
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	53.23	5.46	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	64.09	4.07	1.66
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	55.19	2.68	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	49.88	1.70	1.70
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	49.72	1.60	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	35.12	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	43.62	2.16	1.49
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	51.63	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	56.64	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	46.31	3.26	1.72
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	50.34	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	38.83	1.94	1.94
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	40.98	4.17	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	50.88	3.63	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	45.60	3.42	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	45.75	3.42	1.92
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	50.59	2.32	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	41.76	3.28	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	51.77	4.50	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	58.50	2.14	2.14
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	49.14	1.75	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	55.10	2.71	2.41
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	66.53	4.75	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	50.35	3.56	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	48.14	1.53	3.06
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	48.92	1.27	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	45.31	6.47	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	52.71	2.54	2.12
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	56.84	1.16	2.90
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	53.85	5.67	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	47.30	2.37	1.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	41.69	2.32	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	40.14	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	52.75	1.29	1.29
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	54.75	4.81	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	42.28	2.92	4.37
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	46.67	3.45	1.84
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	61.21	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	61.27	2.80	2.29
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	44.38	1.45	1.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	51.71	2.14	1.84
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	46.85	4.78	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	53.88	2.66	1.77
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	42.72	3.05	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	44.31	2.22	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	50.05	1.85	2.65
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	58.15	2.54	1.09
Astrocyte - cerebellum, donor1	11500-119F6	18.05	1.97	1.60
Astrocyte - cerebellum, donor2	11580-120F5	20.20	2.57	0.68
Astrocyte - cerebellum, donor3	11661-122F5	23.91	0.84	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	17.43	1.05	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	13.59	0.81	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	15.21	1.34	1.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	6.19	0.00	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	5.64	0.00	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	3.87	0.00	0.11
Basophils, donor1	12241-129G9	68.26	2.09	0.52
Basophils, donor2	12242-129H1	49.07	1.08	0.72
Basophils, donor3	12243-129H2	128.92	1.18	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	58.64	1.94	1.51
Bronchial Epithelial Cell, donor2	11591-120G7	258.31	15.54	3.20
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	107.96	3.14	6.90
Bronchial Epithelial Cell, donor5	11457-119A8	102.10	4.37	3.33
Bronchial Epithelial Cell, donor6	11461-119B3	77.84	3.68	1.61
Bronchial Epithelial Cell, donor7	11769-123I5	56.68	3.60	1.44
Burkitt's lymphoma cell line:DAUDI	10422-106C8	13.29	0.10	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	33.07	0.47	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	59.16	0.96	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	118.35	1.69	1.13
CD14+ Monocytes, donor2	11305-117B9	114.14	0.93	1.30
CD14+ Monocytes, donor3	11381-118B4	135.45	1.32	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	102.46	3.96	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	77.71	4.93	2.65
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	98.29	3.29	1.64
CD14+ monocytes - mock treated, donor1	11863-125A9	96.41	1.01	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	57.93	1.51	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	79.12	2.61	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	69.80	1.34	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	41.40	0.83	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	58.51	2.48	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	80.87	1.96	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	58.40	1.60	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	71.17	1.31	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	70.00	1.17	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	52.80	2.64	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	77.66	4.44	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	84.49	1.04	1.34
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	38.71	0.40	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	56.42	1.46	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	87.85	2.06	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	37.32	1.13	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	54.56	0.87	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	84.73	0.54	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	73.10	1.92	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	97.21	1.26	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	78.63	1.84	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	53.19	1.06	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	54.84	1.32	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	78.12	1.74	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	63.56	0.37	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	77.38	1.51	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	72.07	1.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	36.39	1.16	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	56.14	2.09	0.93
CD14+CD16+ Monocytes, donor1	11789-124B7	122.06	3.49	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	146.68	5.08	1.62
CD14+CD16+ Monocytes, donor3	11912-125G4	152.93	4.77	1.08
CD14+CD16- Monocytes, donor1	11788-124B6	321.25	4.98	1.56
CD14+CD16- Monocytes, donor2	11799-124C8	272.45	4.19	1.75
CD14+CD16- Monocytes, donor3	11910-125G2	173.25	1.34	1.56
CD14-CD16+ Monocytes, donor1	11790-124B8	156.93	3.06	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	126.25	3.73	1.54
CD14-CD16+ Monocytes, donor3	11911-125G3	133.07	2.74	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	10.16	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	24.41	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	21.75	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	31.45	1.60	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	13.40	1.07	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	25.97	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	21.18	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	21.09	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	11.51	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	13.06	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	8.58	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	14.14	2.83	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	14.78	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	8.03	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	17.98	1.12	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	68.01	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	55.24	2.25	1.13
CD4+ T Cells, donor1	11225-116C1	14.64	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	32.46	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	20.74	0.61	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	44.16	2.04	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	30.77	1.35	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	35.65	0.86	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	30.82	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	40.03	1.40	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	39.55	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	33.53	1.45	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	37.62	0.85	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	44.98	0.64	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	24.21	2.69	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	37.38	0.35	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	22.44	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	54.81	2.11	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	81.45	2.08	1.25
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	92.89	1.34	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	35.08	1.36	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	38.59	2.14	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	41.24	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	64.71	3.89	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	73.65	1.52	1.52
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	78.18	2.52	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	30.84	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	35.96	0.43	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	29.20	1.74	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	68.29	1.48	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	58.16	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	51.65	0.00	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	68.96	3.88	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	61.84	1.72	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	77.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	71.98	1.07	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	51.24	5.54	0.00
CD8+ T Cells, donor1	11226-116C2	31.76	1.31	0.00
CD8+ T Cells, donor2	11307-117C2	40.17	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	43.68	0.25	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	7.80	1.84	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	8.63	0.96	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	6.57	0.55	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	9.31	1.20	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	7.20	0.72	1.92
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	7.28	0.91	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	6.95	0.65	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	8.69	1.05	1.58
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	6.57	0.94	1.88
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	12.08	1.81	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	9.01	1.45	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	7.73	1.87	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	6.57	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	6.83	0.00	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	3.73	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	9.36	2.16	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	6.33	2.30	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	9.66	0.47	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	7.61	0.63	1.58
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	12.30	0.92	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	9.94	0.96	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	11.47	2.29	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	8.67	1.97	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	7.56	0.76	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	9.64	0.80	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	13.29	0.70	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	11.02	6.01	0.00
Cardiac Myocyte, donor1	11525-119I4	25.59	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	67.20	3.95	1.48
Cardiac Myocyte, donor3	11686-122I3	27.99	1.16	0.53
Chondrocyte - de diff, donor1	11261-116G1	39.52	3.12	1.04
Chondrocyte - de diff, donor2	11338-117F6	22.74	2.49	2.13
Chondrocyte - de diff, donor3	11410-118E6	40.39	1.37	0.80
Chondrocyte - re diff, donor2	11339-117F7	35.81	3.58	1.79
Chondrocyte - re diff, donor3	11411-118E7	87.76	2.83	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	21.23	1.26	0.92
Ciliary Epithelial Cells, donor2	11323-117D9	27.58	1.71	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	27.61	1.50	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	47.87	3.03	1.65
Corneal Epithelial Cells, donor1	11526-119I5	76.19	3.73	0.66
Corneal Epithelial Cells, donor2	11606-120I4	58.02	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	82.82	3.32	1.53
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	14.03	2.64	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	17.66	2.21	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	17.49	1.51	0.97
Dendritic Cells - plasmacytoid, donor1	11228-116C4	11.27	1.37	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	13.71	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	8.71	0.97	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	23.18	2.50	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	24.64	2.93	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	30.26	1.70	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	16.51	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	28.51	1.45	1.75
Endothelial Cells - Artery, donor2	11341-117F9	29.41	3.53	2.35
Endothelial Cells - Artery, donor3	11413-118E9	17.36	1.75	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	23.94	1.77	1.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	28.91	0.91	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	19.73	0.85	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	39.52	4.16	1.78
Endothelial Cells - Microvascular, donor2	11342-117G1	24.47	2.08	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	32.75	1.99	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	36.01	3.20	2.80
Endothelial Cells - Thoracic, donor2	11343-117G2	21.49	2.10	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	33.30	1.62	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	26.29	1.30	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	30.17	2.20	0.85
Endothelial Cells - Vein, donor1	11267-116G7	27.30	7.96	1.14
Endothelial Cells - Vein, donor2	11344-117G3	23.75	1.40	2.10
Endothelial Cells - Vein, donor3	11416-118F3	34.38	4.24	1.10
Eosinophils, donor1	12244-129H3	152.47	0.00	0.00
Eosinophils, donor2	12245-129H4	113.87	3.30	3.30
Eosinophils, donor3	12246-129H5	156.94	3.57	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	97.24	5.13	2.69
Esophageal Epithelial Cells, donor2	11587-120G3	60.32	8.32	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	28.74	2.46	2.05
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	42.81	1.42	1.31
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	17.12	0.54	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	23.41	0.85	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	28.66	1.50	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	36.18	1.58	1.16
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	42.16	3.69	2.37
Fibroblast - Aortic Adventitial, donor3	11401-118D6	37.21	3.99	1.33
Fibroblast - Cardiac, donor1	11268-116G8	31.75	1.36	0.45
Fibroblast - Cardiac, donor2	11345-117G4	34.87	3.03	1.52
Fibroblast - Cardiac, donor3	11417-118F4	37.85	3.47	1.26
Fibroblast - Cardiac, donor4	11452-119A3	17.88	1.21	0.00
Fibroblast - Cardiac, donor5	11456-119A7	43.27	3.30	1.65
Fibroblast - Cardiac, donor6	11460-119B2	37.44	2.73	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	21.71	1.47	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	24.59	0.86	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	55.66	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	28.60	1.61	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	18.49	0.17	0.68
Fibroblast - Dermal, donor1	11269-116G9	24.18	2.11	0.23
Fibroblast - Dermal, donor2	11346-117G5	19.34	3.77	2.83
Fibroblast - Dermal, donor3	11418-118F5	25.39	1.33	0.48
Fibroblast - Dermal, donor4	11450-119A1	16.62	1.58	0.68
Fibroblast - Dermal, donor5	11454-119A5	19.89	0.70	0.52
Fibroblast - Dermal, donor6	11458-119A9	19.17	1.14	0.32
Fibroblast - Gingival, donor1	11237-116D4	25.40	2.08	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	22.79	0.52	1.05
Fibroblast - Gingival, donor2	11318-117D4	19.50	1.05	0.66
Fibroblast - Gingival, donor3	11394-118C8	26.30	1.74	0.68
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	50.91	3.12	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	35.42	2.47	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	27.59	0.94	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	23.39	0.81	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	20.82	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	21.50	2.63	1.17
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	25.23	0.55	0.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	25.78	1.43	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	22.60	1.61	0.59
Fibroblast - Lung, donor1	11270-116H1	23.11	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	10.45	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	34.82	1.90	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	32.49	3.33	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	25.18	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	42.54	2.24	1.12
Fibroblast - Mammary, donor1	11540-120B1	32.88	2.84	0.81
Fibroblast - Mammary, donor2	11620-122A9	15.98	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	5.96	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	15.52	1.36	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	20.33	0.61	1.67
Fibroblast - Periodontal Ligament, donor3	11395-118C9	16.22	1.84	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	17.94	1.53	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	28.08	3.78	2.16
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	48.01	3.13	1.28
Fibroblast - Pulmonary Artery, donor1	11250-116E8	29.84	2.10	1.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	35.15	1.42	1.02
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	30.07	0.67	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	34.40	0.79	1.98
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	15.28	1.79	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	19.36	1.07	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	27.20	0.20	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	40.01	2.71	2.71
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	34.33	1.62	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	18.73	2.53	0.51
Fibroblast - skin normal, donor1	11553-120C5	26.42	0.98	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	34.69	1.60	2.01
Fibroblast - skin normal, donor2	11561-120D4	33.96	2.61	1.31
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	20.25	0.91	2.72
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	24.77	1.16	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	31.63	1.03	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	25.62	0.99	1.97
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	26.95	2.02	0.75
Fibroblast - skin walker warburg, donor1	11554-120C6	21.59	2.19	1.18
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	9.41	1.25	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	30.50	0.00	4.36
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	71.60	4.16	2.25
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	63.24	2.86	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	57.75	3.83	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	92.63	2.30	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	86.14	3.83	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	97.56	7.42	3.42
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	59.56	4.14	4.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	44.98	2.28	1.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	112.54	5.75	2.97
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	51.28	2.38	2.11
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	42.40	1.96	3.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	93.31	3.98	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	61.62	3.25	2.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	41.62	2.46	1.35
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	44.86	2.95	3.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	32.34	4.71	1.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	40.84	3.60	1.66
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	33.34	2.44	2.85
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	35.60	4.11	2.51
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	38.12	3.36	1.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	41.75	2.40	2.19
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	44.32	3.84	3.84
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	43.24	3.97	2.38
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	40.89	2.23	2.46
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	33.27	3.23	2.42
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	38.68	4.07	1.53
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	36.36	3.37	2.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	26.85	2.39	2.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	24.76	3.24	2.90
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	33.42	4.76	1.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	34.94	2.50	3.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	33.69	2.86	2.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	29.30	2.06	2.48
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	33.67	2.65	2.31
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	42.36	3.67	4.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	27.55	2.20	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	30.87	3.32	2.09
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	34.85	2.92	2.11
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	31.11	2.89	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	38.00	3.51	3.41
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	38.75	4.43	1.74
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	29.19	2.43	3.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	32.83	4.50	2.09
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	48.74	3.95	3.29
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	33.67	2.81	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	31.57	2.78	2.69
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	44.92	2.41	2.94
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	35.65	2.75	2.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	48.19	4.79	2.59
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	57.74	5.15	2.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	35.95	2.03	2.58
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	33.99	2.41	1.97
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	30.74	3.97	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	20.71	1.85	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	30.26	1.82	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	32.28	2.03	1.78
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	52.75	3.58	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	66.41	3.54	1.85
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	73.24	4.50	2.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	94.19	3.44	5.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	96.07	4.52	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	59.50	4.15	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	64.34	7.42	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	73.88	4.25	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	102.69	14.44	9.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	67.81	10.43	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	72.91	6.18	4.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	68.77	7.82	5.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	79.97	3.33	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	64.88	5.87	5.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	58.83	5.23	5.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	82.21	9.23	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	65.52	5.09	3.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	68.95	5.77	4.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	114.85	6.26	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	55.55	6.30	8.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	66.89	5.92	5.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	57.60	5.08	8.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	55.50	5.80	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	59.14	3.91	2.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	5.27	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	47.28	5.38	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	60.63	3.91	3.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	79.59	6.02	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	48.93	3.47	2.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	38.00	1.37	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	34.79	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	45.30	3.30	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	51.30	1.81	3.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	51.88	3.05	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	49.06	3.59	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	48.35	3.45	3.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	46.04	1.18	5.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	48.43	4.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	32.92	1.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	30.52	0.85	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	40.59	2.39	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	36.88	1.46	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	39.95	4.57	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	29.11	2.91	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	31.48	4.50	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	26.32	0.63	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	25.06	0.84	1.67
Hep-2 cells mock treated, biol_rep1	11898-125E8	34.12	1.86	1.51
Hep-2 cells mock treated, biol_rep2	11899-125E9	27.68	2.87	1.86
Hep-2 cells mock treated, biol_rep3	11900-125F1	28.89	2.73	1.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	32.46	1.97	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	29.23	3.22	2.15
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	28.20	3.44	1.94
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	30.89	2.49	1.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	24.02	2.57	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	28.51	1.92	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	34.70	1.68	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	22.51	1.30	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	29.08	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	22.93	1.41	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	34.15	0.00	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	46.51	1.57	0.70
Hepatocyte, donor1	11523-119I2	10.90	0.00	0.00
Hepatocyte, donor2	11603-120I1	10.77	2.15	0.00
Hepatocyte, donor3	11684-122I1	18.41	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	15.66	2.61	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	26.04	2.62	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	28.13	2.20	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	47.76	0.00	9.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	113.48	6.68	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	65.07	5.54	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	85.09	20.02	10.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	106.81	11.87	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	64.07	5.13	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	77.70	9.14	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	73.09	11.37	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	50.02	8.34	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	10.89	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	92.64	10.59	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	66.52	9.98	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	86.92	7.56	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	71.14	6.19	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	96.91	7.75	5.17
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	86.94	11.27	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	131.43	11.95	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	63.56	8.15	4.07
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	74.73	9.24	2.10
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	172.47	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	87.60	5.63	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	67.40	5.54	6.46
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	73.17	4.72	5.19
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	62.58	5.44	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	44.23	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	77.48	2.15	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	76.23	3.81	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	82.15	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	73.33	2.55	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	83.84	3.65	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	74.26	6.43	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	49.77	9.95	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	75.62	5.56	3.09
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	56.19	5.27	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	50.29	9.43	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	57.02	4.87	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	99.59	11.07	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	35.66	6.48	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	74.11	11.34	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	110.24	9.00	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	73.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	98.14	10.67	6.40
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	62.34	8.31	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	79.79	2.85	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	98.49	4.60	5.52
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	63.53	6.05	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	74.50	18.63	18.63
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	81.42	13.75	3.17
Keratinocyte - epidermal, donor1	11272-116H3	55.00	1.39	1.22
Keratinocyte - epidermal, donor2	11349-117G8	40.99	1.76	2.34
Keratinocyte - epidermal, donor3	11421-118F8	72.03	2.46	0.85
Keratinocyte - oral, donor1	11251-116E9	50.52	2.50	1.14
Keratocytes, donor1	11527-119I6	26.48	4.13	2.06
Keratocytes, donor2	11607-120I5	32.81	0.00	2.34
Keratocytes, donor3	11688-122I5	23.12	0.59	1.58
Krukenberg tumor cell line:HSKTC	10687-109F3	17.58	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	35.60	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	20.53	1.15	0.69
Lens Epithelial Cells, donor3	11690-122I7	21.19	0.71	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	57.51	5.57	2.37
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	60.56	4.47	5.86
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	65.48	2.99	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	47.86	4.30	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	61.14	2.84	3.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	66.31	4.42	2.80
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	43.50	4.10	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	65.73	4.80	2.53
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	57.00	4.50	3.24
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	37.58	2.37	2.77
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	58.36	3.10	2.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	72.21	4.63	2.22
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	42.86	2.79	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	61.54	2.62	2.62
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	60.98	4.67	2.75
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	41.27	2.77	2.46
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	63.91	2.49	3.12
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	69.17	4.39	2.56
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	47.06	4.28	1.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	65.02	3.22	4.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	72.94	3.98	3.73
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	46.56	4.36	3.39
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	53.05	4.85	1.89
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	57.07	5.30	2.88
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	47.69	2.59	2.59
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	56.95	2.51	1.88
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	58.95	2.71	2.71
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	40.58	2.06	4.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	48.92	4.14	2.82
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	59.38	2.65	2.12
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	34.89	3.88	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	49.62	1.65	1.98
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	63.06	3.96	2.60
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	47.76	3.70	2.96
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	51.39	4.20	3.46
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	56.92	2.47	3.16
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	42.78	3.22	3.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	50.82	3.35	2.43
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	51.79	3.22	2.52
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	39.47	3.91	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	61.08	2.91	2.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	71.89	3.11	2.96
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	50.13	6.09	1.79
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	49.00	1.31	1.96
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	72.04	5.89	3.30
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	44.18	3.09	2.48
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	52.51	2.05	3.07
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	48.04	3.28	2.09
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	15.86	6.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	32.22	4.60	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	16.33	2.23	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	21.58	3.81	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	26.73	2.81	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	25.22	3.74	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	20.61	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	30.93	2.38	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	25.79	2.49	2.26
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	17.45	1.74	1.74
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	20.71	1.35	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	30.76	3.12	2.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	30.81	1.03	3.59
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	21.88	3.53	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	15.99	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	23.94	2.55	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	23.21	1.33	1.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	24.94	3.21	1.32
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	25.77	1.84	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	33.43	2.45	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	22.49	1.67	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	25.22	1.96	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	24.73	2.06	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	22.64	3.19	1.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	20.63	2.69	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	24.34	2.21	2.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	26.87	2.83	2.83
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	23.97	1.48	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	34.54	0.00	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	28.40	3.84	3.07
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	20.95	1.70	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	30.36	3.28	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	23.50	2.71	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	23.70	2.15	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	25.39	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	24.53	2.60	3.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	18.95	0.43	3.02
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	23.98	3.43	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	26.65	3.00	2.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	24.13	2.41	3.02
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	25.60	2.13	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	23.72	3.09	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	18.79	1.61	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	28.28	0.67	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	22.97	2.22	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	20.93	2.33	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	21.15	3.17	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	29.21	3.20	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	29.07	2.18	3.63
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	33.73	4.60	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	23.68	2.47	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	19.76	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	27.66	3.52	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	27.04	1.80	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	21.82	4.01	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	25.81	2.35	3.13
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	22.43	1.98	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	26.98	3.63	2.59
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	21.00	3.50	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	25.16	1.68	4.47
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	28.71	3.97	2.65
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	27.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	25.32	2.53	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	24.99	4.33	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	27.83	2.78	2.78
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	13.98	3.04	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	24.90	0.69	2.77
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	22.04	2.28	2.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	25.30	4.13	3.10
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	22.98	1.81	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	23.13	3.49	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	19.72	2.13	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	24.71	1.15	2.87
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	22.11	2.06	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	29.00	0.71	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	26.10	2.27	4.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	27.04	4.16	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	21.14	2.35	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	29.65	2.92	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	25.09	5.58	2.79
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	18.06	0.67	3.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	27.27	5.88	2.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	22.63	2.83	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	18.36	3.67	3.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	26.67	3.56	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	29.63	2.28	4.56
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	19.94	3.07	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	24.62	1.64	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	20.49	3.56	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	26.26	2.60	1.82
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	22.55	2.65	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	45.73	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	74.30	3.65	1.37
Macrophage - monocyte derived, donor2	11313-117C8	71.20	3.49	1.47
Macrophage - monocyte derived, donor3	11389-118C3	122.82	6.03	2.36
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	49.92	6.37	1.06
Mallassez-derived cells, donor2	11929-125I3	28.84	2.06	0.63
Mallassez-derived cells, donor3	11930-125I4	34.47	3.89	0.28
Mammary Epithelial Cell, donor1	11273-116H4	85.10	6.58	3.09
Mammary Epithelial Cell, donor2	11350-117G9	47.78	2.32	1.45
Mammary Epithelial Cell, donor3	11422-118F9	64.60	3.49	2.24
Mast cell - stimulated, donor1	11487-119E2	8.14	0.00	0.00
Mast cell, donor1	11563-120D6	64.34	1.41	0.54
Mast cell, donor2	11565-120D8	59.14	1.49	0.30
Mast cell, donor3	11566-120D9	109.19	2.48	1.80
Mast cell, donor4	11567-120E1	102.30	2.66	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	42.36	1.89	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	39.11	1.75	1.17
Mast cell, expanded, donor5	11939-126A4	156.60	2.98	1.61
Mast cell, expanded, donor8	11941-126A6	195.48	2.51	1.51
Melanocyte - dark, donor1	11502-119F8	41.29	2.29	1.19
Melanocyte - dark, donor2	11582-120F7	55.03	3.81	1.73
Melanocyte - dark, donor3	11663-122F7	42.81	1.96	2.32
Melanocyte - light, donor1	11274-116H5	30.56	2.82	2.12
Melanocyte - light, donor2	11351-117H1	34.81	6.14	3.41
Melanocyte - light, donor3	11423-118G1	31.22	5.20	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	40.19	4.37	2.92
Melanocyte, donor2 (MC+2)	12739-135I3	61.86	2.42	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	28.12	1.34	1.34
Meningeal Cells, donor1	11493-119E8	27.42	3.23	1.74
Meningeal Cells, donor2	11573-120E7	23.33	0.88	0.88
Meningeal Cells, donor3	11654-122E7	26.16	0.90	1.39
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	17.39	1.14	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	34.01	1.41	0.91
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	91.99	5.26	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	58.87	1.31	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	50.23	3.59	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	22.24	1.06	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	19.10	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	28.57	2.86	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	16.07	1.46	4.38
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	33.96	3.07	1.43
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	24.52	0.97	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	63.56	1.86	1.86
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	31.58	0.53	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	16.62	1.19	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	35.03	2.34	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	65.96	2.56	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	37.22	2.84	1.77
Mesenchymal stem cells - hepatic, donor0	11218-116B3	28.46	1.25	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	69.67	1.45	1.45
Mesothelial Cells, donor1	11247-116E5	56.75	3.71	1.33
Mesothelial Cells, donor2	12156-128G5	46.04	2.50	1.00
Mesothelial Cells, donor3	11402-118D7	46.61	2.38	0.79
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	29.71	5.40	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	45.07	3.69	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	41.81	2.65	1.47
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	42.77	3.41	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	47.92	1.87	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	30.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	51.55	2.25	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	39.57	1.40	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	40.03	3.05	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	47.12	0.79	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	8.55	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	35.40	2.65	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	49.39	1.14	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	23.69	0.00	3.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	35.87	1.70	1.49
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	30.39	2.76	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	26.53	2.09	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	0.00	3.35
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	33.37	1.76	1.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	37.55	0.48	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	13.27	1.11	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	30.62	1.15	1.61
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	31.76	1.05	1.68
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	21.61	1.43	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	28.75	1.93	1.07
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	29.56	0.44	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	17.96	0.88	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	22.31	1.01	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	21.20	0.82	1.09
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	26.17	1.18	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	29.31	1.92	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	27.62	0.40	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	16.45	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	23.53	2.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	26.28	3.50	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	17.66	3.31	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	16.01	1.92	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	29.50	2.48	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	20.88	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	24.31	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	55.73	2.39	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	25.82	1.75	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	25.92	2.13	1.07
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	48.82	2.24	1.96
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	29.93	2.08	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	29.72	0.58	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	46.76	2.11	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	42.57	4.17	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	33.25	0.92	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	56.91	3.98	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	31.51	1.66	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	50.53	4.15	2.59
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	55.34	2.14	1.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	31.12	2.54	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	36.83	0.80	1.60
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	94.59	2.99	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	39.27	2.68	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	72.30	3.19	3.82
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	79.61	3.76	2.21
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	29.58	1.14	1.52
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	63.92	3.69	2.84
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	92.18	5.16	2.95
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	59.30	3.26	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	54.40	2.06	2.94
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	104.37	6.92	4.90
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	73.77	2.89	2.47
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	60.15	3.28	2.08
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	116.77	15.07	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	89.11	5.35	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	113.69	3.61	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	129.39	7.36	3.16
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	105.96	4.15	1.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	73.57	3.73	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	53.70	1.88	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	68.98	4.00	1.60
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	72.61	2.60	0.68
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	96.51	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	75.48	2.56	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	66.89	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	36.88	0.53	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	65.69	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	132.30	7.07	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	50.60	3.37	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	9.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.99	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	12.15	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	18.13	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	16.80	1.51	1.94
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	22.47	2.09	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	35.38	2.00	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	23.37	2.50	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	12.74	1.14	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	19.15	3.19	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	24.48	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	29.30	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	22.78	2.79	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	27.29	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	23.13	1.26	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	37.23	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	20.03	0.54	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	29.70	1.36	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	27.11	1.14	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	33.90	1.82	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	34.48	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	42.62	1.20	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	6.89	1.31	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	25.86	0.81	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	22.40	1.41	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	29.54	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	29.88	1.38	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	43.38	1.29	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	6.21	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	22.50	0.67	1.11
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	24.56	2.54	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	14.48	2.61	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	51.94	1.29	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	36.99	2.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	29.76	1.35	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	31.74	0.40	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	52.00	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	30.65	3.78	1.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	33.57	1.30	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	30.07	1.74	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	25.78	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	48.50	5.29	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	44.54	0.00	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	54.07	0.50	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	32.54	1.53	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	40.53	2.42	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	34.70	1.33	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	39.98	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	62.80	4.88	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	28.64	1.57	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	25.42	2.12	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	45.89	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	15.87	0.00	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	5.06
Myoblast, donor1	11241-116D8	31.55	1.49	0.87
Myoblast, donor2	11322-117D8	48.52	2.11	1.34
Myoblast, donor3	11398-118D3	41.20	2.52	1.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	82.74	0.58	0.15
Natural Killer Cells, donor1	11230-116C6	57.81	0.92	0.31
Natural Killer Cells, donor2	11311-117C6	41.31	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	50.80	0.55	0.74
Neural stem cells, donor1	11275-116H6	15.61	1.45	1.45
Neural stem cells, donor2	11352-117H2	7.70	0.00	1.93
Neurons, donor1	11494-119E9	14.79	1.14	1.14
Neurons, donor2	11574-120E8	13.65	0.88	0.66
Neurons, donor3	11655-122E8	11.51	0.82	0.00
Neutrophils, donor1	11233-116C9	129.92	0.93	1.86
Neutrophils, donor2	11314-117C9	144.94	0.00	0.00
Neutrophils, donor3	11390-118C4	195.47	4.28	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	19.24	0.83	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	30.61	1.30	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	22.06	2.61	1.00
Olfactory epithelial cells, donor1	11933-125I7	15.14	0.69	0.00
Olfactory epithelial cells, donor2	11934-125I8	34.59	1.45	0.00
Olfactory epithelial cells, donor3	11935-125I9	34.16	1.59	0.57
Olfactory epithelial cells, donor4	11936-126A1	24.84	1.17	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	61.39	4.21	0.60
Osteoblast - differentiated, donor1	11276-116H7	25.31	2.34	1.06
Osteoblast - differentiated, donor2	11353-117H3	44.58	2.29	1.14
Osteoblast - differentiated, donor3	11425-118G3	34.14	6.21	0.62
Osteoblast, donor1	11277-116H8	33.22	1.95	0.59
Osteoblast, donor2	11354-117H4	16.15	1.40	0.00
Osteoblast, donor3	11426-118G4	30.21	2.84	0.89
Pancreatic stromal cells, donor1	11249-116E7	19.21	1.43	0.51
Pericytes, donor1	11491-119E6	25.37	2.23	1.45
Pericytes, donor2	11571-120E5	26.03	2.49	1.81
Pericytes, donor3	11652-122E5	30.11	2.85	1.02
Perineurial Cells, donor1	11499-119F5	25.77	2.94	1.13
Perineurial Cells, donor2	11579-120F4	65.51	2.76	1.56
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	86.70	0.64	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	102.84	1.47	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	80.11	1.16	0.65
Placental Epithelial Cells, donor1	11278-116H9	32.77	4.30	1.43
Placental Epithelial Cells, donor2	11355-117H5	35.48	3.33	2.22
Placental Epithelial Cells, donor3	11427-118G5	18.85	2.55	2.16
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	59.49	1.90	3.16
Preadipocyte - breast, donor1	11467-119B9	45.58	1.69	1.31
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	20.75	1.70	0.65
Preadipocyte - breast, donor2	11328-117E5	55.61	3.60	1.58
Preadipocyte - omental, donor1	11468-119C1	52.96	1.70	1.81
Preadipocyte - omental, donor2	11329-117E6	39.28	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	55.72	3.01	2.58
Preadipocyte - perirenal, donor1	11469-119C2	72.84	2.95	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	36.85	2.15	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	37.01	0.89	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	37.29	1.87	0.68
Preadipocyte - visceral, donor1	11280-116I2	15.74	1.12	0.37
Preadipocyte - visceral, donor2	11357-117H7	38.66	1.84	1.84
Preadipocyte - visceral, donor3	11429-118G7	19.96	1.78	1.04
Prostate Epithelial Cells (polarized), donor1	11253-116F2	22.02	3.32	1.51
Prostate Epithelial Cells, donor2	11331-117E8	54.30	2.71	1.08
Prostate Epithelial Cells, donor3	11404-118D9	24.25	1.90	0.61
Prostate Stromal Cells, donor1	11254-116F3	40.09	1.59	1.14
Prostate Stromal Cells, donor2	11332-117E9	36.94	0.90	0.72
Prostate Stromal Cells, donor3	11405-118E1	43.17	1.36	1.15
Renal Cortical Epithelial Cells, donor1	11516-119H4	41.24	2.55	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	28.28	1.59	0.97
Renal Epithelial Cells, donor1	11517-119H5	62.90	6.09	3.04
Renal Epithelial Cells, donor2	11597-120H4	34.85	2.13	2.85
Renal Epithelial Cells, donor3	11678-122H4	24.45	0.95	1.27
Renal Glomerular Endothelial Cells, donor1	11514-119H2	31.32	5.45	2.72
Renal Glomerular Endothelial Cells, donor2	11594-120H1	35.85	2.70	1.35
Renal Glomerular Endothelial Cells, donor3	11675-122H1	16.21	1.78	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	33.94	4.66	2.66
Renal Mesangial Cells, donor1	11518-119H6	27.07	1.32	1.32
Renal Mesangial Cells, donor2	11598-120H5	38.87	1.88	0.63
Renal Mesangial Cells, donor3	11679-122H5	46.88	3.05	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	38.65	6.44	2.42
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	40.48	4.22	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	29.31	2.12	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	40.71	3.63	1.56
Retinal Pigment Epithelial Cells, donor1	11528-119I7	30.13	1.42	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	44.25	2.06	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	22.83	0.75	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	30.20	1.87	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	38.42	2.68	3.57
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	11.01	2.75	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	8.12	2.90	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	22.36	4.16	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	29.00	3.67	2.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	28.11	2.12	1.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	21.71	2.11	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	34.26	3.15	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	30.28	5.32	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	27.11	3.15	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	25.87	2.87	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	32.97	4.48	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	28.83	3.73	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	30.80	4.08	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	37.39	5.53	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	20.65	1.91	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	28.23	2.89	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	24.05	1.50	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	24.68	3.45	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	21.61	3.31	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	25.02	4.39	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	24.35	3.63	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	22.14	1.68	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	25.29	4.44	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	26.80	4.92	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	26.00	2.58	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	25.52	3.49	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	28.30	4.72	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	25.00	2.78	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	26.66	4.68	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	27.79	2.28	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	23.01	4.20	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	30.08	3.97	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	24.23	2.42	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	24.01	2.04	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	26.41	2.70	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	22.01	2.41	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	22.91	3.84	2.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	19.37	3.12	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	25.22	3.24	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	27.96	2.66	2.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	25.32	1.87	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	30.70	5.12	3.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	31.19	5.00	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	28.82	2.62	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	30.51	4.80	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	36.33	2.79	3.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	27.20	3.32	3.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	31.94	5.14	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	41.34	3.20	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	46.85	5.48	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	36.77	3.32	2.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	54.06	8.60	4.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	42.83	5.09	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	44.75	10.39	3.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	50.16	7.90	2.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	39.66	4.21	1.80
Schwann Cells, donor1	11498-119F4	45.70	4.51	3.95
Schwann Cells, donor2	11578-120F3	13.61	0.00	0.00
Schwann Cells, donor3	11659-122F3	42.50	3.94	1.53
Sebocyte, donor1	11220-116B5	37.80	2.19	0.55
Sebocyte, donor2	11301-117B5	42.74	0.92	0.46
Sebocyte, donor3	11378-118B1	50.70	2.68	0.62
Sertoli Cells, donor1	11255-116F4	48.04	1.66	0.00
Sertoli Cells, donor2	11333-117F1	48.01	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	22.26	1.58	0.79
Skeletal Muscle Cells, donor2	11358-117H8	32.53	6.51	0.72
Skeletal Muscle Cells, donor3	11430-118G8	35.11	8.36	0.00
Skeletal Muscle Cells, donor4	11451-119A2	35.19	2.36	1.41
Skeletal Muscle Cells, donor5	11455-119A6	36.42	1.93	1.19
Skeletal Muscle Cells, donor6	11459-119B1	33.40	2.77	2.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	42.21	0.63	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	33.96	1.43	1.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	34.33	1.98	2.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	22.75	1.10	0.84
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	20.27	3.62	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	20.50	1.65	1.24
Skin - palm, donor1	10286-104F7	42.98	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	62.13	3.46	1.87
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	33.53	4.09	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	65.30	2.08	1.69
Small Airway Epithelial Cells, donor1	11256-116F5	54.07	1.95	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	47.54	2.53	1.41
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	68.30	4.23	2.54
Small Airway Epithelial Cells, donor3	11406-118E2	31.93	1.87	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	12.03	1.54	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	42.47	2.89	1.33
Smooth Muscle Cells - Aortic, donor0	11210-116A4	41.74	4.11	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	51.93	2.65	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	32.29	1.97	2.76
Smooth Muscle Cells - Aortic, donor3	11432-118H1	44.04	2.32	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	34.03	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	34.87	1.33	1.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	24.16	1.99	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	33.67	2.18	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	22.47	2.93	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	29.53	1.77	2.07
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	41.86	1.28	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	27.82	2.28	0.98
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	20.40	0.61	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	45.71	3.28	1.77
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	38.62	3.34	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	28.02	1.47	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	28.84	1.72	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	31.91	1.15	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	32.79	3.71	2.01
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	42.04	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	60.37	2.69	2.09
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	46.77	2.39	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	45.70	0.79	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	15.00	0.91	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	125.38	2.28	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	64.00	5.43	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	30.73	1.32	2.38
Smooth Muscle Cells - Prostate, donor1	11257-116F6	42.48	1.73	1.07
Smooth Muscle Cells - Prostate, donor2	11335-117F3	31.93	1.13	1.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	33.99	0.76	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	37.99	2.11	1.96
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	42.76	2.25	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	15.51	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	33.02	3.26	3.26
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	45.94	1.51	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	45.44	2.19	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	27.43	0.59	1.47
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	20.33	1.25	1.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	24.29	0.47	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	20.72	2.45	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	28.05	2.55	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	25.95	2.82	1.13
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	16.21	0.56	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	26.90	1.93	1.01
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	88.57	5.24	2.86
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	18.59	1.47	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	29.61	1.77	1.33
Smooth Muscle Cells - Uterine, donor3	11466-119B8	47.69	1.46	3.51
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	39.46	0.97	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	21.42	1.06	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	12.27	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	22.28	1.44	1.80
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	26.12	2.27	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	15.75	1.18	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	27.93	1.78	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	32.34	2.80	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	39.71	1.25	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	39.88	0.92	0.92
Synoviocyte, donor1	11291-117A4	14.14	1.68	0.50
Synoviocyte, donor2	11368-117I9	66.71	2.01	1.34
Synoviocyte, donor3	11440-118H9	82.89	4.69	2.01
Trabecular Meshwork Cells, donor1	11532-120A2	28.94	1.79	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	41.62	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	31.26	1.16	1.85
Tracheal Epithelial Cells, donor1	11292-117A5	50.54	2.15	1.29
Tracheal Epithelial Cells, donor2	11369-118A1	67.26	3.48	1.93
Tracheal Epithelial Cells, donor3	11441-118I1	95.63	3.44	2.29
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	31.99	1.85	0.62
Urethra, donor2	10319-105A4	19.78	3.60	1.80
Urothelial Cells, donor1	11520-119H8	68.81	5.31	0.80
Urothelial Cells, donor2	11600-120H7	92.53	3.20	3.61
Urothelial Cells, donor3	11681-122H7	105.66	3.21	1.38
Urothelial cells, donor0	11216-116B1	90.94	4.68	2.90
Whole blood (ribopure), donor090309, donation1	12179-129A1	152.15	7.12	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	191.57	5.72	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	151.96	2.74	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	123.96	3.44	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	131.31	5.81	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	183.26	7.29	4.16
Whole blood (ribopure), donor090612, donation2	12183-129A5	167.96	2.75	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	125.07	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	46.51	1.85	1.36
Wilms' tumor cell line:HFWT	10597-108E3	20.24	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	63.96	2.23	1.68
achilles tendon, donor2	10292-104G4	37.20	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	7.14	0.51	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	14.86	0.70	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	4.15	0.36	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	20.41	0.54	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	51.16	1.12	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	133.66	1.69	2.75
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	30.49	0.27	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	121.18	3.97	3.08
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	52.27	2.45	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	57.08	1.55	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	90.16	1.66	1.29
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	58.51	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	24.63	1.16	1.63
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	16.57	0.78	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	35.95	1.46	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	77.61	0.93	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	70.32	1.23	2.06
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	47.58	3.99	2.46
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	66.99	2.99	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	42.46	3.03	1.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	50.55	3.37	1.68
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	84.64	2.23	1.56
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	68.04	3.34	2.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	14.87	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	31.40	1.31	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	33.74	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	37.68	1.18	0.47
adipose tissue, adult, pool1	10010-101C1	24.66	1.40	0.47
adipose, donor1	10184-103D4	14.66	0.59	1.76
adipose, donor2	10185-103D5	36.50	1.22	3.24
adipose, donor3	10186-103D6	40.57	0.82	1.91
adipose, donor4	10187-103D7	49.40	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	27.46	4.58	3.63
adrenal gland, adult, pool1	10081-102A9	18.19	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	45.36	1.60	1.07
alveolar cell carcinoma cell line:SW 1573	10708-109H6	20.01	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	19.01	3.94	0.23
amniotic membrane cells, donor2	12236-129G4	30.09	2.37	1.35
amniotic membrane cells, donor3	12237-129G5	13.85	2.36	0.88
amygdala - adult, donor10196	10167-103B5	9.49	0.00	2.37
amygdala, adult, donor10252	10151-102I7	18.65	0.41	0.61
amygdala, newborn, donor10223	10360-105E9	14.85	0.65	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	25.85	1.40	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	25.81	1.32	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	22.38	1.00	1.34
aorta, adult, pool1	10052-101G7	25.11	0.98	0.20
appendix, adult	10189-103D9	18.63	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	27.17	3.44	2.06
artery, adult	10190-103E1	17.66	1.36	2.72
astrocytoma cell line:TM-31	10425-106D2	17.82	1.74	0.29
b cell line:RPMI1788	10427-106D4	5.50	0.45	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	22.47	0.83	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	18.46	1.79	0.89
bile duct carcinoma cell line:TFK-1	10496-107C1	30.63	2.68	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	44.18	1.12	0.00
bladder, adult, pool1	10011-101C2	23.79	0.54	0.43
blood, adult, pool1	10053-101G8	93.01	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	17.13	1.71	0.00
bone marrow, adult	10192-103E3	21.59	0.67	0.67
brain, adult, donor1	10084-102B3	16.40	1.03	0.00
brain, adult, pool1	10012-101C3	11.92	0.78	0.78
brain, fetal, pool1	10085-102B4	5.34	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	8.26	0.33	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	27.71	1.37	0.50
breast, adult, donor1	10080-102A8	39.14	1.26	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	28.46	3.56	1.91
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	30.30	2.16	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	15.19	2.76	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	27.11	2.18	2.18
carcinoid cell line:NCI-H1770	10703-109H1	31.97	2.82	0.94
carcinoid cell line:NCI-H727	10735-110B6	9.63	1.31	0.77
carcinoid cell line:SK-PN-DW	10719-109I8	34.86	1.27	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	8.78	0.80	0.80
caudate nucleus - adult, donor10196	10177-103C6	14.97	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	13.89	0.84	0.17
caudate nucleus, adult, donor10258	10379-105H1	13.75	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	9.52	0.73	0.73
cerebellum - adult, donor10196	10173-103C2	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	4.48	0.43	0.00
cerebellum, adult, pool1	10083-102B2	9.31	0.00	0.69
cerebellum, newborn, donor10223	10357-105E6	9.96	0.00	0.00
cerebral meninges, adult	10188-103D8	11.60	0.76	1.26
cerebrospinal fluid, donor2	10294-104G6	13.16	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	42.27	1.73	1.87
cervical cancer cell line:ME-180	10553-107I4	29.33	0.83	0.66
cervix, adult, pool1	10013-101C4	26.25	0.94	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	118.16	3.20	1.39
chondrosarcoma cell line:SW 1353	10700-109G7	18.29	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	14.42	1.49	3.11
choriocarcinoma cell line:SCH	10785-110H2	16.88	1.36	1.60
choriocarcinoma cell line:T3M-3	10618-108G6	9.96	7.12	4.98
chorionic membrane cells, donor1	12238-129G6	25.93	4.27	2.28
chorionic membrane cells, donor2	12239-129G7	24.66	2.78	1.29
chorionic membrane cells, donor3	12240-129G8	15.39	4.40	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	66.47	2.50	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	40.13	1.06	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	40.32	2.31	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	43.54	1.45	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	32.58	0.81	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	48.29	2.65	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	38.31	0.52	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	35.43	5.49	2.06
clear cell carcinoma cell line:TEN	10636-108I6	48.06	4.86	3.30
colon carcinoma cell line:CACO-2	10513-107D9	59.85	5.31	2.20
colon carcinoma cell line:COLO-320	10420-106C6	25.85	2.28	3.04
colon, adult, donor1	10082-102B1	34.51	0.00	0.00
colon, adult, pool1	10014-101C5	17.98	0.82	0.24
colon, fetal, donor1	10070-101I7	27.81	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	36.67	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	9.35	0.85	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	12.83	0.60	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	14.52	0.56	0.56
corpus callosum, adult, pool1	10042-101F6	37.15	2.10	1.88
cruciate ligament, donor2	10295-104G7	30.80	0.81	2.43
diaphragm, fetal, donor1	10069-101I6	28.09	0.00	0.80
diencephalon, adult	10193-103E4	10.80	0.48	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	7.81	0.69	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	30.00	3.08	1.54
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	47.90	0.72	1.44
ductus deferens, adult	10196-103E7	27.41	1.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	31.69	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	20.60	2.21	0.74
dura mater, adult, donor1	10041-101F5	65.24	1.49	1.40
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	18.65	2.44	4.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	21.06	1.58	3.01
embryonic pancreas cell line:1B2C6	10604-108F1	16.65	0.62	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	26.94	2.12	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	13.89	1.54	0.93
embryonic pancreas cell line:2C6	10603-108E9	21.02	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	33.52	3.35	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	42.05	5.98	2.17
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	23.00	3.22	1.45
epidermoid carcinoma cell line:A431	10426-106D3	53.69	1.89	1.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	37.40	1.54	0.77
epididymis, adult	10197-103E8	63.84	2.72	2.09
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	35.13	2.66	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	19.66	1.18	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	49.54	2.88	2.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	42.52	1.67	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	58.14	2.13	0.90
esophagus, adult, pool1	10015-101C6	30.05	0.85	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	26.55	1.63	1.00
eye - muscle inferior rectus, donor1	10272-104E2	33.80	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	27.35	0.00	0.00
eye - muscle medial, donor2	10299-104H2	26.79	0.00	1.49
eye - muscle superior, donor2	10297-104G9	21.78	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	34.98	1.46	1.46
eye, fetal, donor1	10054-101G9	23.64	2.03	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	29.62	2.31	0.90
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	69.56	4.75	2.37
frontal lobe, adult, pool1	10040-101F4	8.44	0.75	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	44.74	2.70	2.10
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	54.40	3.66	1.65
gall bladder, adult	10198-103E9	22.94	1.93	0.48
gamma delta positive T cells, donor1	11937-126A2	112.20	3.22	2.15
gamma delta positive T cells, donor2	11938-126A3	137.07	3.36	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	57.45	2.75	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	30.17	3.29	0.77
gastric cancer cell line:AZ521	10549-107H9	34.59	7.54	2.95
gastric cancer cell line:GSS	10560-108A2	8.24	1.83	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	43.86	2.28	1.60
giant cell carcinoma cell line:LU65	10487-107B1	8.72	0.80	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	26.73	2.66	2.10
glassy cell carcinoma cell line:HOKUG	10688-109F4	58.11	6.24	3.24
glioblastoma cell line:A172, tech_rep1	10444-106F3	14.14	0.53	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	16.01	0.56	0.98
glioblastoma cell line:T98G	10485-107A8	36.31	1.88	1.32
glioma cell line:GI-1	10413-106B8	16.11	3.51	1.17
globus pallidus - adult, donor10196	10175-103C4	23.33	2.19	0.00
globus pallidus, adult, donor10252	10161-103A8	29.05	1.22	1.46
globus pallidus, adult, donor10258	10367-105F7	10.95	0.00	2.74
globus pallidus, newborn, donor10223	10364-105F4	26.65	1.60	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	88.10	4.89	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	98.36	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	78.40	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	10.56	0.32	0.64
hIPS +CCl2, biol_rep1	14383-156B9	45.45	3.21	1.38
hIPS +CCl2, biol_rep2	14384-156C1	41.61	2.29	2.29
hIPS +CCl2, biol_rep3	14385-156C2	44.44	3.86	1.93
hIPS, biol_rep1	14380-156B6	28.75	1.44	0.00
hIPS, biol_rep2	14381-156B7	38.41	1.37	0.69
hIPS, biol_rep3	14382-156B8	18.76	2.21	2.21
hairy cell leukemia cell line:Mo	10712-109I1	9.19	0.29	0.29
heart - mitral valve, adult	10205-103F7	19.73	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	15.69	0.78	0.52
heart - tricuspid valve, adult	10207-103F9	53.29	3.33	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	42.04	3.06	1.84
heart, adult, diseased, donor1	10051-101G6	25.98	1.28	1.28
heart, adult, pool1	10016-101C7	17.25	1.15	0.69
heart, fetal, pool1	10046-101G1	21.15	1.13	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	49.36	6.48	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	29.73	7.14	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	34.25	1.22	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	29.62	0.85	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	32.84	0.81	0.71
hepatoma cell line:Li-7	10484-107A7	19.13	0.89	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	37.99	1.61	1.01
hippocampus - adult, donor10196	10169-103B7	14.19	2.84	2.84
hippocampus, adult, donor10252	10153-102I9	22.86	0.20	0.41
hippocampus, adult, donor10258	10374-105G5	3.49	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	14.45	0.70	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	50.05	2.44	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	101.32	3.73	3.14
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	100.29	3.05	2.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	45.67	3.38	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	48.80	2.58	1.81
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	45.55	1.90	4.18
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	36.79	0.88	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	36.19	2.15	2.37
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	37.54	2.50	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	41.20	4.26	3.08
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	45.32	2.09	1.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	43.09	3.37	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	91.39	2.19	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	90.40	1.47	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	48.87	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	49.83	2.10	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	42.30	3.05	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	43.48	0.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	32.03	0.94	1.70
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	33.19	3.18	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	25.37	2.82	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	47.85	1.96	3.27
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	48.77	2.32	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	49.62	2.09	2.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	88.86	2.22	1.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	95.57	4.28	2.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	66.15	2.04	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	58.09	2.82	3.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	61.13	4.12	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	62.04	3.03	4.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	49.13	4.14	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	45.16	3.32	5.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	42.58	2.05	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	50.36	4.86	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	48.46	5.30	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	54.78	3.36	2.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	88.39	4.11	1.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	83.34	2.23	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	101.46	7.32	4.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	47.07	3.06	3.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	16.27	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	33.76	3.31	2.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	37.76	0.55	3.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	40.17	2.53	3.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	34.16	1.07	2.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	38.19	2.39	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	42.66	3.93	3.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	47.95	2.42	2.96
immature langerhans cells, donor1	11904-125F5	3.87	0.00	0.00
immature langerhans cells, donor2	11905-125F6	11.88	0.79	0.00
insula, adult, pool1	10039-101F3	11.73	0.85	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	95.92	6.18	1.63
kidney, adult, pool1	10017-101C8	49.36	1.70	2.10
kidney, fetal, pool1	10045-101F9	37.84	2.83	1.63
large cell lung carcinoma cell line:IA-LM	10509-107D5	20.74	1.14	1.56
large cell lung carcinoma cell line:NCI-H460	10839-111E2	34.84	1.24	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	21.47	2.39	0.37
left atrium, adult, donor1	10079-102A7	21.79	1.09	1.63
left ventricle, adult, donor1	10078-102A6	35.90	1.52	0.00
leiomyoblastoma cell line:G-402	10721-110A1	29.82	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	38.44	2.51	1.08
leiomyoma cell line:15242A	10570-108B3	34.78	0.54	1.09
leiomyoma cell line:15425	10571-108B4	29.14	1.21	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	20.91	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	9.80	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	19.53	2.34	0.62
liposarcoma cell line:SW 872	10726-110A6	35.33	2.19	0.61
liver, adult, pool1	10018-101C9	12.80	0.81	0.16
liver, fetal, pool1	10086-102B5	22.58	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	14.00	0.44	0.73
locus coeruleus, adult, donor10252	10165-103B3	14.21	1.85	0.37
locus coeruleus, adult, donor10258	10375-105G6	29.06	0.56	1.69
locus coeruleus, newborn, donor10223	10362-105F2	10.52	0.00	0.84
lung adenocarcinoma cell line:A549	10499-107C4	26.71	3.60	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	30.33	3.45	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	19.90	1.45	1.32
lung, adult, pool1	10019-101D1	41.58	2.13	0.95
lung, fetal, donor1	10068-101I5	29.68	2.57	2.00
lung, right lower lobe, adult, donor1	10075-102A3	53.61	2.29	0.00
lymph node, adult, donor1	10077-102A5	45.44	1.89	1.42
lymphangiectasia cell line:DS-1	10727-110A7	8.77	1.53	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	6.64	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	24.64	0.85	0.85
mature adipocyte, donor1	12231-129F8	12.88	1.78	0.89
mature adipocyte, donor2	12232-129F9	10.79	0.62	0.21
mature adipocyte, donor3	12233-129G1	9.48	0.71	0.00
mature adipocyte, donor4	12234-129G2	9.74	2.63	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	25.49	2.86	1.91
medial frontal gyrus - adult, donor10196	10170-103B8	6.77	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	13.24	0.55	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	9.21	0.95	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	5.12	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	7.59	0.34	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	17.61	0.85	1.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	7.54	0.72	0.00
medulla oblongata - adult, donor10196	10174-103C3	40.89	1.30	1.30
medulla oblongata, adult, donor10252	10155-103A2	25.08	0.46	0.46
medulla oblongata, adult, pool1	10038-101F2	25.14	1.39	0.98
medulla oblongata, newborn, donor10223	10361-105F1	31.94	1.39	1.39
medulloblastoma cell line:D283 Med	10838-111E1	19.04	3.54	1.55
medulloblastoma cell line:ONS-76	10759-110E3	36.44	2.93	1.83
melanoma cell line:COLO 679	10514-107E1	23.86	3.59	2.01
melanoma cell line:G-361	10465-106H6	23.89	2.71	2.44
meningioma cell line:HKBMM	10691-109F7	35.46	1.81	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	14.98	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	24.63	0.78	3.11
mesenchymal precursor cell - adipose, donor1	11747-123G1	44.04	2.15	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	37.08	2.73	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	35.20	3.73	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	25.15	1.40	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	33.70	2.50	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	50.67	2.08	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	41.54	3.95	1.54
mesenchymal precursor cell - cardiac, donor2	11753-123G7	24.61	2.42	0.92
mesenchymal precursor cell - cardiac, donor3	11754-123G8	39.66	2.39	1.59
mesenchymal precursor cell - cardiac, donor4	11755-123G9	65.49	3.38	1.89
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	31.16	1.85	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	66.53	3.95	3.62
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	47.88	3.32	1.52
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	44.68	2.09	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	44.30	3.06	1.22
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	29.83	3.24	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	44.38	3.52	1.45
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	24.62	1.37	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	30.63	2.52	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	33.77	2.99	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	33.26	1.93	0.61
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	46.76	2.95	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	25.75	1.72	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	8.84	0.42	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	22.38	1.83	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	26.35	1.02	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	19.37	2.62	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	22.80	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	20.71	1.41	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	24.03	0.68	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	22.01	2.36	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	21.32	0.93	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	27.40	2.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	23.20	1.34	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	22.83	0.96	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	27.87	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	22.15	0.67	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	26.20	1.64	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	23.20	0.43	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	22.41	1.30	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	21.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	41.58	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	20.44	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	20.99	3.11	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	29.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	23.84	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	30.24	0.59	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	19.50	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	22.17	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	20.69	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	21.49	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	25.67	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	15.89	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.69	1.18	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	13.71	1.25	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	16.04	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	8.28	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	11.01	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	16.33	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	15.27	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	29.82	2.42	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	34.89	4.36	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	22.81	2.53	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	14.57	0.61	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	12.36	0.00	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	25.99	1.39	1.39
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	29.20	0.97	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	20.37	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	10.83	0.77	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	20.08	4.25	1.89
mesothelioma cell line:ACC-MESO-4	10494-107B8	40.08	1.85	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	34.63	1.03	0.21
mesothelioma cell line:Mero-25	10850-111F4	21.56	1.13	0.23
mesothelioma cell line:Mero-41	10851-111F5	27.63	1.96	0.73
mesothelioma cell line:Mero-48a	10852-111F6	13.06	0.89	0.22
mesothelioma cell line:Mero-82	10853-111F7	35.74	1.84	1.31
mesothelioma cell line:Mero-83	10854-111F8	18.89	0.51	0.00
mesothelioma cell line:Mero-84	10855-111F9	17.95	0.00	0.76
mesothelioma cell line:Mero-95	10856-111G1	79.50	5.59	1.86
mesothelioma cell line:NCI-H2052	10847-111F1	15.24	2.15	0.99
mesothelioma cell line:NCI-H226	10846-111E9	36.56	1.63	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	44.41	1.54	1.37
mesothelioma cell line:NCI-H28	10845-111E8	10.94	0.51	0.76
mesothelioma cell line:No36	10857-111G2	29.36	2.61	1.30
mesothelioma cell line:ONE58	10858-111G3	60.42	1.90	1.08
migratory langerhans cells, donor1	11901-125F2	2.30	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	5.25	0.61	0.12
migratory langerhans cells, donor3	11903-125F4	4.49	0.54	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	37.22	2.29	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	74.60	3.39	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	20.04	2.30	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	4.76	0.38	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	117.16	6.28	2.77
myeloma cell line:PCM6	10474-106I6	107.14	3.95	1.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	17.25	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	94.54	5.30	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	38.55	1.67	0.89
nasal epithelial cells, donor1, tech_rep2	12226-129F3	35.52	2.79	1.40
nasal epithelial cells, donor2	12227-129F4	60.72	3.86	2.21
neuroblastoma cell line:CHP-134	10508-107D4	6.90	1.38	1.15
neuroblastoma cell line:NB-1	10539-107G8	3.74	0.75	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	60.10	3.16	1.90
neuroblastoma cell line:NH-12	10555-107I6	3.73	0.37	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	18.98	0.47	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	35.32	0.95	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	52.13	2.01	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	17.80	1.91	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	23.95	1.06	0.53
neutrophil PMN, donor1	12133-128D9	178.50	0.00	0.00
neutrophil PMN, donor2	12137-128E4	345.30	13.28	0.00
neutrophil PMN, donor3	12141-128E8	236.77	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	3.89	0.00	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	3.20	1.60	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	32.70	3.85	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	52.55	2.63	0.26
nucleus accumbens, adult, pool1	10037-101F1	11.62	0.75	0.84
occipital cortex - adult, donor10196	10172-103C1	4.12	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	18.79	0.81	1.07
occipital cortex, newborn, donor10223	10355-105E4	9.46	0.36	0.73
occipital lobe, adult, donor1	10076-102A4	16.01	1.57	0.52
occipital lobe, fetal, donor1	10073-102A1	3.86	0.00	0.00
occipital pole, adult, pool1	10036-101E9	9.86	0.87	0.39
olfactory region, adult	10195-103E6	10.89	0.96	0.19
optic nerve, donor1	10277-104E7	28.01	4.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	39.30	1.25	1.37
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	26.93	1.10	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	24.89	0.85	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	32.92	1.50	1.16
osteoclastoma cell line:Hs 706.T	10704-109H2	32.63	1.47	1.76
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	38.31	5.61	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	15.06	0.64	1.06
ovary, adult, pool1	10020-101D2	23.76	1.31	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	32.81	1.65	1.10
pancreas, adult, donor1	10049-101G4	37.63	2.82	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	16.21	5.03	2.24
papillary adenocarcinoma cell line:8505C	10437-106E5	31.86	4.09	1.70
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	50.17	2.48	1.16
paracentral gyrus, adult, pool1	10035-101E8	9.88	0.18	0.55
parietal cortex, adult, donor10258	10373-105G4	5.14	0.00	1.47
parietal lobe - adult, donor10196	10171-103B9	5.64	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	11.69	0.86	0.57
parietal lobe, adult, pool1	10034-101E7	11.19	1.06	0.62
parietal lobe, fetal, donor1	10072-101I9	6.79	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	9.35	0.37	0.37
parotid gland, adult	10199-103F1	45.02	3.70	0.62
penis, adult	10200-103F2	21.48	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	10.23	0.00	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	44.73	1.60	1.31
pineal gland - adult, donor10196	10179-103C8	18.06	4.52	3.23
pineal gland, adult, donor10252	10160-103A7	17.17	3.55	2.37
pineal gland, adult, donor10258	10377-105G8	18.81	0.63	2.51
pituitary gland - adult, donor10196	10180-103C9	23.27	2.02	3.04
pituitary gland, adult, donor10252	10162-103A9	17.72	2.08	0.52
pituitary gland, adult, donor10258	10378-105G9	18.73	1.70	0.85
placenta, adult, pool1	10021-101D3	21.93	1.40	1.40
plasma cell leukemia cell line:ARH-77	10840-111E3	5.16	0.40	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	27.24	1.56	0.16
pons, adult, pool1	10033-101E6	10.59	0.86	0.60
postcentral gyrus, adult, pool1	10032-101E5	9.15	0.35	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	140.12	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	247.86	0.00	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	117.36	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	31.03	2.91	1.75
prostate cancer cell line:PC-3	10439-106E7	39.75	3.09	1.45
prostate, adult, pool1	10022-101D4	35.19	1.09	0.73
putamen, adult, donor10196	10176-103C5	9.21	0.24	0.47
putamen, adult, donor10252	10152-102I8	11.76	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	13.11	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	6.52	0.48	0.97
putamen, newborn, donor10223	10365-105F5	4.50	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	14.55	2.91	0.87
rectum, fetal, donor1	10067-101I4	38.95	0.00	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	43.04	2.33	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	33.97	2.07	0.41
retina, adult, pool1	10030-101E3	34.29	2.29	1.79
retinoblastoma cell line:Y79	10475-106I7	33.51	0.78	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	42.66	2.09	0.74
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	19.68	1.41	1.41
sacrococcigeal teratoma cell line:HTST	10695-109G2	29.56	1.52	0.00
salivary acinar cells, donor1	11771-123I7	53.57	3.08	0.49
salivary acinar cells, donor2	11772-123I8	56.59	2.34	0.69
salivary acinar cells, donor3	11773-123I9	54.29	2.65	3.97
salivary gland, adult, pool1	10093-102C3	25.74	1.72	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	35.24	2.95	2.45
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	47.73	4.00	2.70
seminal vesicle, adult	10201-103F3	23.28	0.53	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	31.58	2.92	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	49.32	3.02	2.52
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	60.21	6.02	4.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	7.52	1.88	2.15
signet ring carcinoma cell line:Kato III	10436-106E4	27.08	1.77	1.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	19.10	0.90	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	31.92	1.42	0.71
skeletal muscle, adult, pool1	10023-101D5	40.90	1.56	0.72
skeletal muscle, fetal, donor1	10066-101I3	30.15	1.01	1.01
skin, adult, donor1	10074-102A2	54.28	6.79	0.00
skin, fetal, donor1	10065-101I2	30.30	2.52	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	15.01	3.34	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	15.45	0.32	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	43.95	10.02	5.78
small cell lung carcinoma cell line:LK-2	10541-107H1	11.21	1.65	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	16.25	2.90	2.25
small cell lung carcinoma cell line:WA-hT	10562-108A4	24.62	3.49	1.96
small intestine, adult, pool1	10024-101D6	12.18	0.24	0.36
small intestine, fetal, donor1	10064-101I1	20.88	0.49	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	29.24	4.10	1.03
smooth muscle, adult, pool1	10048-101G3	20.16	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	6.97	1.88	0.27
spinal cord - adult, donor10196	10181-103D1	25.92	0.46	0.46
spinal cord, adult, donor10252	10159-103A6	24.05	1.58	1.97
spinal cord, adult, donor10258	10369-105F9	13.14	1.38	0.69
spinal cord, fetal, donor1	10056-101H2	38.42	3.66	2.44
spinal cord, newborn, donor10223	10359-105E8	20.21	1.38	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	30.77	1.64	1.05
spleen, adult, pool1	10025-101D7	39.32	1.54	0.66
spleen, fetal, pool1	10044-101F8	36.23	2.07	1.27
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	8.28	0.31	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	23.54	1.71	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	35.99	4.54	2.80
squamous cell carcinoma cell line:T3M-5	10616-108G4	90.31	6.65	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	46.60	2.36	1.24
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	16.94	0.85	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	20.73	2.12	1.27
stomach, fetal, donor1	10062-101H8	36.31	1.07	0.00
submaxillary gland, adult	10202-103F4	23.93	1.14	1.14
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	28.66	1.25	1.45
substantia nigra, adult, donor10258	10371-105G2	10.35	2.07	1.03
substantia nigra, newborn, donor10223	10358-105E7	19.78	2.12	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	22.24	1.83	0.69
temporal lobe, adult, pool1	10031-101E4	16.53	0.51	0.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	7.12	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	6.15	0.88	0.88
tenocyte, donor1	11763-123H8	48.53	2.09	1.05
tenocyte, donor2	11765-123I1	52.27	1.91	1.14
tenocyte, donor3	11768-123I4	25.58	0.74	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	55.41	7.14	6.46
teratocarcinoma cell line:NCR-G1	10798-110I6	28.67	1.70	0.77
teratocarcinoma cell line:PA-1	10807-111A6	44.94	4.65	3.25
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	44.43	4.82	4.32
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	26.47	3.78	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	28.90	7.31	5.45
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	20.52	3.91	3.26
testis, adult, pool1	10026-101D8	36.40	3.11	2.58
testis, adult, pool2	10096-102C6	33.83	3.61	6.77
thalamus - adult, donor10196	10168-103B6	19.87	5.52	1.10
thalamus, adult, donor10252	10154-103A1	23.75	0.78	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	12.32	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	19.10	0.49	0.66
thalamus, newborn, donor10223	10366-105F6	3.45	1.15	0.58
throat, adult	10209-103G2	22.97	1.00	0.50
throat, fetal, donor1	10061-101H7	30.47	1.83	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	47.50	0.99	1.39
thymus, adult, pool1	10027-101D9	20.08	0.89	0.50
thymus, fetal, pool1	10043-101F7	41.77	1.56	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	46.54	3.06	1.73
thyroid carcinoma cell line:TCO-1	10783-110G9	42.19	3.07	0.98
thyroid, adult, pool1	10028-101E1	45.44	3.83	1.40
thyroid, fetal, donor1	10060-101H6	31.11	1.32	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	64.67	0.00	3.08
tongue, adult	10203-103F5	18.14	0.70	0.70
tongue, fetal, donor1	10059-101H5	16.95	0.79	1.18
tonsil, adult, pool1	10047-101G2	29.05	1.20	1.00
trachea, adult, pool1	10029-101E2	42.86	2.21	1.72
trachea, fetal, donor1	10058-101H4	24.62	2.69	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	34.72	0.71	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	39.11	2.63	1.32
transitional-cell carcinoma cell line:JMSU1	10492-107B6	82.73	1.72	2.19
tridermal teratoma cell line:HGRT	10694-109G1	41.86	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	30.64	2.12	1.27
umbilical cord, fetal, donor1	10057-101H3	27.12	0.00	4.17
uterus, adult, pool1	10100-102D1	21.33	1.37	0.51
uterus, fetal, donor1	10055-101H1	29.18	2.05	2.05
vagina, adult	10204-103F6	37.48	0.65	1.94
vein, adult	10191-103E2	20.17	0.88	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	4.81	0.27	0.00

Property "Nearest transcripts" (as page type) with input value "ENST00000476512.5:37 ENST00000400895.6:44 ENST00000494437.1:50 ENST00000314340.10:56 NM_001040195.2:56 NM_001040194.2:56 NM_020350.5:56 NM_001040196.2:56 NM_001040197.2:56 ENST00000491346.5:62 AK290042:62 ENST00000376629.8:67 BC017328:67 ENST00000376627.6:73 AF312374:75 ENST00000452018.6:93 ENST00000510878.1:95 BC011946:99 KJ899301:122 AB528670:129 DQ892619:129 DQ895859:129 AF165187:129" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.